## Background: Nod2 mutations are associated with crohn's disease (cd) in caucasian clinic-based cohorts. data from population-based cohorts are limited. clinic-based studies may overestimate this association. genotype-phenotype relationships are yet to be assessed using the montreal classification
Impact of interobserver disagreement on phenotype–genotype associations in Crohn's disease
✍ Scribed by Anna Oefferlbauer-Ernst; Wolfgang Miehsler; Otto Eckmüllner; Simon Travis; Thomas Waldhoer; Clemens Dejaco; Alfred Gangl; Harald Vogelsang; Walter Reinisch
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 102 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
✦ Synopsis
Background:
Nonvalidated definitions of disease-related parameters in inflammatory bowel disease cause variations in diagnosis and disease classification. we determined interobserver agreement on applications of definitions of the vienna classification variables and computed the potential influence of misclassification on genotype/phenotype associations.
Methods:
Ten records of patients with crohn's disease (cd) were independently evaluated by 19 observers using a standardized inflammatory bowel disease documentation system, which included the vienna classification. interobserver agreement (ioa) was calculated as a percentage of the observers' agreement with a predetermined reference observer and by cohen's kappa. randomized reclassifications were then computed with 10,000 simulation runs using the ioa results and published nod2/card15 gene status. a chi-square independence test was calculated for each simulation run.
Results:
Ioa for location and behavior was 70% (k = 0.57) and 95% (k = 0.91), respectively. ioa for location subgroups ranged from 48% to 88% and for behavior from 91% to 97%. by including the results of histopathology into the evaluation of location, the overall ioa increased significantly, to 80% (p = 0.019). assuming a true genotype/phenotype association, the proportion of studies with nonsignificant findings (p > 0.05) because of the observed misclassification of location ranged from 13.3% to 63.8% and of behavior from 0.2% to 22.2%, depending on a study sample size of 500 or 150 patients respectively.
Conclusions:
We concluded that there is appreciable interobserver disagreement on the location of cd according to the original vienna classification that may obscure true genotype/phenotype associations. definitions of disease parameters have to be validated before being used as the bases for classifications.
📜 SIMILAR VOLUMES
Eight genotypes (A-H) of hepatitis B virus (HBV) have been identified. However, the impact of different genotypes on the clinical course of hepatitis B infection remains controversial. We investigated the frequency and clinical outcome of HBV genotypes and genotype mixtures in HBV-infected patients
## Background: Infliximab is efficacious in the management of moderate to severe crohn's disease (cd). there are limited data regarding performance of infliximab in patients who require reinitiation of maintenance dosing following previous irregular exposure. ## Methods: This was a retrospective,
## Background: Long-term enteral nutrition may maintain clinical and endoscopic remission in patients with crohn's disease (cd). the aim of this prospective study was to investigate the impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal tissue cytokines
## Background: The leukocyte function associated antigen-1 (LFA-1) intracellular adhesion molecule-1 pathway is presumed to play a pivotal role in the perpetuation of inflammatory bowel disease. We aimed to elucidate the effect of 2 different therapies on LFA-1 expression in patients with Crohn's